 "Vaccine")
Top virologist says will not take Covaxin until efficacy data is out
India's national drug regulator has approved the Covid-19 vaccines of both Serum Institute of India (SII) and Bharat Biotech for restricted use in the country. However, experts have severely criticised the regulator for clearing Bharat Biotech's Covaxin even though the efficacy data is available yet. Noted Indian virologist Gagandeep Kang shares her views in a report in The Hindu.
Kang said Bharat Biotech has data from animal challenge studies that are "supportive" of efficacy, but that doesn't automatically imply human efficacy. From humans, the drugmaker must be following up their
